These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates. Gillett MP; Obineche EN; Khan ST; Abdulle AM Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187 [TBL] [Abstract][Full Text] [Related]
8. Analysis of 7-ketocholesterol in low density lipoprotein and fatty acid composition in erythrocyte membranes of patients on maintenance hemodialysis and healthy controls. Tsuzuki D; Sumino K; Yokoyama M Clin Chim Acta; 2000 May; 295(1-2):155-68. PubMed ID: 10767401 [TBL] [Abstract][Full Text] [Related]
9. The compositional abnormalities of lipoproteins in diabetic renal failure. Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487 [TBL] [Abstract][Full Text] [Related]
10. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Attman PO; Alaupovic P; Tavella M; Knight-Gibson C Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654 [TBL] [Abstract][Full Text] [Related]
11. Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure patients. Mekki K; Prost J; Remaoun M; Belleville J; Bouchenak M BMC Cardiovasc Disord; 2009 Aug; 9():41. PubMed ID: 19709414 [TBL] [Abstract][Full Text] [Related]
12. Alterations in lipoprotein composition in peritoneal dialysis patients. Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P Perit Dial Int; 2002; 22(2):220-8. PubMed ID: 11990407 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054 [TBL] [Abstract][Full Text] [Related]
14. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects. Hughes TA; Stentz F; Gettys T; Smith SR Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916 [TBL] [Abstract][Full Text] [Related]
15. Long-term effects of cis and trans monounsaturated (18:1) and saturated (16:0) fatty acids on the synthesis and secretion of apolipoprotein A-I- and apolipoprotein B-containing lipoproteins in HepG2 cells. Dashti N; Feng Q; Franklin FA J Lipid Res; 2000 Dec; 41(12):1980-90. PubMed ID: 11108731 [TBL] [Abstract][Full Text] [Related]
16. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Attman PO; Alaupovic P Nephron; 1991; 57(4):401-10. PubMed ID: 2046821 [TBL] [Abstract][Full Text] [Related]
17. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids. Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580 [TBL] [Abstract][Full Text] [Related]
18. Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study. Zheng JS; Sharp SJ; Imamura F; Koulman A; Schulze MB; Ye Z; Griffin J; Guevara M; Huerta JM; Kröger J; Sluijs I; Agudo A; Barricarte A; Boeing H; Colorado-Yohar S; Dow C; Dorronsoro M; Dinesen PT; Fagherazzi G; Franks PW; Feskens EJM; Kühn T; Katzke VA; Key TJ; Khaw KT; de Magistris MS; Mancini FR; Molina-Portillo E; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Ricceri F; Spijkerman AMW; Slimani N; Tagliabue G; Tjonneland A; Tumino R; van der Schouw YT; Langenberg C; Riboli E; Forouhi NG; Wareham NJ BMC Med; 2017 Nov; 15(1):203. PubMed ID: 29145892 [TBL] [Abstract][Full Text] [Related]
19. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892 [TBL] [Abstract][Full Text] [Related]